Curcumin exhibited its therapeutic efficiency in lung cancer treatment by means of the downregulation of NF-κB in human lung cancer cell lines A549 and also by acting on the JAK2/STAT3 signaling pathway, inhibiting JAK2 activity [13,38]. This evidence concerns the gene JAK2 and lung cancer.